100 related articles for article (PubMed ID: 29195903)
1. Reply to Foley et al., "Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation?".
Sorigue M; Juncà J
Cancer Genet; 2018 Jan; 220():77. PubMed ID: 29195903
[No Abstract] [Full Text] [Related]
2. Discussion on reply to Foley et al., 'Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation?'.
Mannis GN
Cancer Genet; 2018 Jan; 220():77-78. PubMed ID: 29246709
[No Abstract] [Full Text] [Related]
3. Acute myeloid leukemia with t(14;21) involving RUNX1 and SYNE2: A novel favorable-risk translocation?
Foley N; Van Ziffle J; Yu J; Qi Z; Grenert JP; Yeh I; Bastian B; Kogan S; Mannis GN
Cancer Genet; 2017 Oct; 216-217():74-78. PubMed ID: 29025598
[TBL] [Abstract][Full Text] [Related]
4. A Novel Three-Way Variant t(8;13;21)(q22;q33;q22) in a Child with Acute Myeloid Leukemia with RUNX1/RUNX1T1 : The Contribution of Molecular Approaches for Revealing t(8;21) Variants.
de Matos RR; De Figueiredo AF; Liehr T; Alhourani E; De Souza MT; Binato R; Ribeiro RC; Silva ML
Acta Haematol; 2015; 134(4):243-5. PubMed ID: 26138995
[No Abstract] [Full Text] [Related]
5. Identification of RUNX1 gene breakage and copy number variation in acute myeloid leukemia.
Li L; Qi XL; Chen XH; Ren FG; Xu ZF; Tan YH; Yang SY; Pan J; Xu J; Li J; Wang HW
Int J Lab Hematol; 2016 Apr; 38(2):e23-6. PubMed ID: 26696592
[No Abstract] [Full Text] [Related]
6. Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders.
Metzeler KH; Bloomfield CD
Adv Exp Med Biol; 2017; 962():175-199. PubMed ID: 28299658
[TBL] [Abstract][Full Text] [Related]
7. A novel four-way t(6;16;21;8)(p21.3;p11.2;q22;q22) in acute myeloid leukemia with RUNX1/RUNX1T1 rearrangement.
Park KJ; Park HD; Kim HJ; Yoo KH; Koo HH; Kim SH
Cancer Genet Cytogenet; 2009 Jul; 192(2):90-2. PubMed ID: 19596262
[No Abstract] [Full Text] [Related]
8. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia (M2) with a cryptic RUNX1/RUNX1T1 t(1;21;8)(p36;q22;q22) variant.
Tirado CA; Chen W; Valdez FJ; Henderson S; Doolittle J; Garcia R; Patel S; Holdridge S; Chastain C; Collins RH
Cancer Genet Cytogenet; 2009 Aug; 193(1):67-9. PubMed ID: 19602466
[No Abstract] [Full Text] [Related]
10. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1.
Liu H; Wang SA; Schlette EJ; Xu J; Jorgensen JL; Cameron Yin C; Li S; Jeffrey Medeiros L; Tang G
Ann Hematol; 2018 Oct; 97(10):1775-1783. PubMed ID: 29872884
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome sequencing reveals CHD1 as a novel fusion partner of RUNX1 in acute myeloid leukemia with t(5;21)(q21;q22).
Yao H; Pan J; Wu C; Shen H; Xie J; Wang Q; Wen L; Wang Q; Ma L; Wu L; Ping N; Zhao Y; Sun A; Chen S
Mol Cancer; 2015 Apr; 14():81. PubMed ID: 25879624
[TBL] [Abstract][Full Text] [Related]
12. Two novel translocations disrupt the RUNX1 gene in acute myeloid leukemia.
Dai H; Xue Y; Pan J; Wu Y; Wang Y; Shen J; Zhang J
Cancer Genet Cytogenet; 2007 Sep; 177(2):120-4. PubMed ID: 17854666
[TBL] [Abstract][Full Text] [Related]
13. A Novel KIT INDEL Mutation in Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1.
Lee JH; Park C; Kim SH; Shin MG
Ann Lab Med; 2016 Jul; 36(4):371-4. PubMed ID: 27139612
[No Abstract] [Full Text] [Related]
14. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
[TBL] [Abstract][Full Text] [Related]
15. Distinct clonal anomalies involving RUNX1 in acute myeloid leukemia at diagnosis and after bone marrow transplantation.
De Braekeleer E; Douet-Guilbert N; Basinko A; Le Bris MJ; Morel F; Berthou C; Férec C; De Braekeleer M
Ann Hematol; 2010 Dec; 89(12):1277-81. PubMed ID: 20352434
[No Abstract] [Full Text] [Related]
16. A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22).
Abe A; Katsumi A; Kobayashi M; Okamoto A; Tokuda M; Kanie T; Yamamoto Y; Naoe T; Emi N
Cancer Genet; 2012 Nov; 205(11):608-11. PubMed ID: 23102734
[TBL] [Abstract][Full Text] [Related]
17. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
[TBL] [Abstract][Full Text] [Related]
18. Reply to "rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated cases". Haematologica 2014;99(2):e20-21.
Mendler JH; Marcucci G; Bloomfield CD
Haematologica; 2014 Feb; 99(2):e22. PubMed ID: 24497566
[No Abstract] [Full Text] [Related]
19. Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies.
Sakurai M; Nannya Y; Yamazaki R; Yamaguchi K; Koda Y; Abe R; Yokoyama K; Ogawa S; Mori T
Ann Hematol; 2022 Jan; 101(1):237-239. PubMed ID: 33462643
[No Abstract] [Full Text] [Related]
20. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.
Duployez N; Nibourel O; Marceau-Renaut A; Willekens C; Helevaut N; Caillault A; Villenet C; Celli-Lebras K; Boissel N; Jourdan E; Dombret H; Figeac M; Preudhomme C; Renneville A
Am J Hematol; 2014 Jun; 89(6):610-5. PubMed ID: 24616160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
